Skip to main content
SCM Lifescience Co., Ltd. logo

SCM Lifescience Co., Ltd. — Investor Relations & Filings

Ticker · 298060 ISIN · KR7298060005 KO Manufacturing
Open in API
Filings indexed 418 across all filing types
Latest filing 2025-03-18 AGM Information
Country KR South Korea
Listing KO 298060

About SCM Lifescience Co., Ltd.

http://www.scmlifescience.com/en/

SCM Lifescience Co., Ltd. is a biotechnology company focused on developing high-purity, high-efficacy stem cell therapeutics for difficult-to-treat and incurable diseases. The company utilizes its proprietary source technology, the Subfractionation Culturing Method, to isolate and culture potent stem cells. Its pipeline consists of allogeneic stem cell therapies targeting immunological conditions, which are undergoing clinical trials. SCM Lifescience is also establishing mass production manufacturing processes using 3D bioreactor technology and expanding its research into induced pluripotent stem cells (iPSC) and tissue engineering. The company's business areas also include contract manufacturing (CMO), contract research, consulting, and cosmetics.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for SCM Life Science Co., Ltd. It includes details about the meeting date, location, agenda items (financial statement approval, director/auditor appointments), and voting procedures (including electronic voting). It also contains sections on board activities and business overviews, which are standard components of a formal shareholder meeting notice/proxy statement in the Korean market. This document is a formal notification and solicitation for a shareholder meeting, fitting the definition of a Proxy Solicitation & Information Statement.
2025-03-18 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) filed with the Korean financial authorities. It details the issuance of new shares, the purpose of the capital raise (facility and operating funds), the third-party allocation method, and the specific financial terms of the issuance. This falls under the category of announcements regarding new share issues or capital changes.
2025-03-17 Korean
주권매매거래정지 (관리종목지정우려)
Delisting Announcement Classification · 100% confidence The document is a short, official regulatory notice regarding the suspension of stock trading for SCM Life Science Co., Ltd. due to concerns about being designated as an administrative issue (management stock). It cites specific KOSDAQ market regulations and provides the reason for the suspension. Since it is a regulatory announcement regarding market status and does not fit into specific categories like M&A or financial reports, it falls under the general regulatory filing category.
2025-03-14 Korean
내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생
Delisting Announcement Classification · 100% confidence The document is a regulatory filing from SCM Lifescience regarding the occurrence of grounds for designation as an administrative issue, formal delisting, and substantive review of listing eligibility due to internal financial results. It provides financial data (revenue, operating profit, net profit) and details regarding capital impairment and loss ratios. While it contains financial data, it is a specific regulatory disclosure required by the exchange when certain financial thresholds are breached, rather than a standard quarterly or annual report. Therefore, it is classified as a Regulatory Filing (RNS).
2025-03-14 Korean
기타시장안내(관리종목지정우려종목)
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice from the Korea Exchange regarding SCM Lifescience, warning about the potential designation as an administrative issue (management stock) due to financial losses. It is a regulatory announcement regarding market status and does not fit into specific categories like financial reports or dividends, making it a general regulatory filing.
2025-03-14 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by SCM Lifescience. It outlines the date, location, and agenda items (financial statement approval, director/auditor appointments, and remuneration limits). This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2025-03-14 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.